Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
iTeos Therapeutics, Inc. (ITOS) had Cash Flow from Financial Activities of $4.53M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-78.73M |
|
-- |
|
-- |
|
$83.79M |
|
$-83.79M |
|
$6.73M |
|
$-77.06M |
|
$-77.06M |
|
$-78.73M |
|
$-78.73M |
|
$-78.73M |
|
$-78.73M |
|
$-83.79M |
|
$-80.99M |
|
43.56M |
|
43.56M |
|
$-1.81 |
|
$-1.81 |
|
| Balance Sheet Financials | |
$528.99M |
|
$5.17M |
|
$94.09M |
|
$623.08M |
|
$70.27M |
|
-- |
|
$59.01M |
|
$129.28M |
|
$493.80M |
|
$493.80M |
|
$493.80M |
|
38.27M |
|
| Cash Flow Statement Financials | |
$-76.21M |
|
$134.65M |
|
|
Cash Flow from Financial Activities |
$4.53M |
$142.43M |
|
$208.14M |
|
$65.71M |
|
$12.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-76.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.94% |
|
-15.94% |
|
-12.64% |
|
-15.94% |
|
$12.90 |
|
$-1.76 |
|
$-1.75 |
|